Connect with us
One of the grant projects is a clinical trial to improve the prognosis of acute lymphoblastic leukemia in children under one year of age, the most...
That headline. Sounds too good to be true, right? 5-minute AI-powered workout rewinds body clock by 10 years. That’s what we thought, too. Then we saw...
Biogen reports a positive balance in 2023 with $9.8 billion in revenues, a 3% decrease. Q4 2023 sales were $2.4 billion, down 6% from the same...
Qube Research & Technologies increases its short position on Grifols to 1.23%, up from 1.19%, amid market volatility due to the conflict with Gotham City Research....
Regarding the priorities of the Spanish health and biotechnology industries, first is the implementation of new tools and technologies, followed by the promotion of the culture...
UrbanFisio raises one million euros in its latest investment round, with French insurance group IMA and individual investors joining as new partners. The funding aims for...
The current project will last two years and will be financed by the Next Generation funds managed by the Center for Technological Development and Innovation (Cdti)...
Wegovy stands as Novo Nordisk's big bet. This medicine was what placed the Danish multinational company as the most valuable company in Europe last September, surpassing...
Eli Lilly's U.S. revenues grew by 39% to 6,188.1 million euros, with international revenues up 10% to 2.7 billion euros. R&D costs rose by 29.5%, while...
BlackRock increased its stake in Grifols to 4.2% amid the Spanish company's legal dispute with Gotham City Research. The 4.1% rise in Grifols' stock boosted the...
 |
|
 |  |
 |
|